INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 128 filers reported holding INTERSECT ENT INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $1,641,000 | -77.3% | 138,497 | -52.4% | 0.01% | -72.2% |
Q4 2019 | $7,240,000 | +133.6% | 290,760 | +59.6% | 0.02% | +125.0% |
Q3 2019 | $3,099,000 | -83.6% | 182,177 | -69.0% | 0.01% | -83.0% |
Q1 2019 | $18,866,000 | -20.8% | 586,800 | -30.6% | 0.05% | -29.9% |
Q4 2018 | $23,812,000 | +359.3% | 844,980 | +368.7% | 0.07% | +509.1% |
Q3 2018 | $5,184,000 | -18.3% | 180,300 | +6.4% | 0.01% | -26.7% |
Q2 2018 | $6,348,000 | -3.2% | 169,500 | +1.6% | 0.02% | 0.0% |
Q1 2018 | $6,559,000 | +21.3% | 166,900 | 0.0% | 0.02% | +25.0% |
Q4 2017 | $5,408,000 | +10.4% | 166,900 | +6.2% | 0.01% | +9.1% |
Q3 2017 | $4,897,000 | +11.4% | 157,200 | 0.0% | 0.01% | +10.0% |
Q2 2017 | $4,394,000 | +63.0% | 157,200 | 0.0% | 0.01% | +66.7% |
Q1 2017 | $2,696,000 | +41.7% | 157,200 | 0.0% | 0.01% | +50.0% |
Q4 2016 | $1,902,000 | -23.6% | 157,200 | 0.0% | 0.00% | -20.0% |
Q3 2016 | $2,490,000 | -33.8% | 157,200 | -46.0% | 0.01% | -37.5% |
Q2 2016 | $3,763,000 | -70.7% | 291,000 | -57.0% | 0.01% | -66.7% |
Q1 2016 | $12,863,000 | -15.7% | 677,048 | -0.1% | 0.02% | -4.0% |
Q4 2015 | $15,251,000 | -25.4% | 677,850 | -22.5% | 0.02% | -26.5% |
Q3 2015 | $20,456,000 | +2.4% | 874,174 | +25.3% | 0.03% | +17.2% |
Q2 2015 | $19,979,000 | +157.1% | 697,810 | +131.9% | 0.03% | +163.6% |
Q1 2015 | $7,772,000 | – | 300,903 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|